Biologics (incl. regenerative med.), Biotech (incl. agriculture), CDMO, Medical Device, Smart Health&Precision Health, Small Molecule Drug, Government / Non-Profit Institution

DM Brochure

Welcome to visit Taiwan Pavilion at booth No. 1917 & 1817 in Bio 2024!
BPIPO is honored to organize Taiwan delegation with over 50 companies and organizations in new drug, CDMO, regenerative medicine, agriculture biotechnology, precision medicine, and smart health fields are looking forward to meeting you on-site.
Not only companies’ collaboration information, but also Taiwan's biomedical policy, and unique environment you can find here!

Taiwan has promoted the biomedical industry for decades. The efforts of the government and private enterprises have laid the cornerstone for the cross-domain development of biomedicine. The following videos show the current state of Taiwan's biomedical industry innovation, development, and Taiwan’s biotechnology focus.

Biologics
Biotech
(incl. agriculture)
CDMO
Medical Device
Small Molecule Drug
Smart &
Precision Health
Government
Non-Profit Institution

Anivance AI

▪ In-/Out-Licensing
▪ Collaborative R&D
▪ CRO Partnerships
▪ CDMO Services
▪ Technology Platforms
▪ Analytics as a Service (AaaS)

CytoAurora Biotechnologies

▪ Out licensing
▪ Collaborative R&D
▪ Instrument sales

FaceHeart Corporation

FaceHeart provides a cross-platform Software Development Kit (SDK) or Web page for any players who are interested in adopting contactless vital sign measurements as part of their service offerings.
▪ Hardware Vendors (IDH/ODM/OEM)
▪ Medical Channels
▪ Value-added Service Providers
▪ Smart Health Application/Management
▪ SmartHealth Service Solution/Platform.

Marker Exploration Corporation (Marker X)

1. Out Licensing: Early Cancer Detection Platform Technology Licensing.
2. Collaborative R&D: Collaborating with Medical Centers, Hospitals, and Clinics to Develop Precision Cancer or Other Disease Screening Services.
3. LDTs & IVD: Laboratory Services for Early Cancer Screening and Developing IVDs
4. Cross-Industry Collaboration: Integrating Services with the Insurance Industry.

Neurobit Technologies

▪ Sales Partners
▪ Dealers
▪ Distributors

JelloX Biotech Inc.

In-/Out-Licensing, Collaborative R&D, and Collaborative new drug development.

ACRO Biomedical Co., Ltd

▪ Distribution (代理/經銷)
▪ ODM/OEM (委託設計/製造/生產)
▪ R&D Collaboration (研發合作)
▪ Licensing (授權)

BIONET Corp.

CRDMO opportunities for regenerative medicine techniques, bioinformatic service, and precise medicine development with biomedicine companies.

CytoArm Co.,Ltd.

▪ Out-Licensing of Armed-T cell Technology and Products
▪ Clinical Trial Collaboration
▪ Fundraising

LumiSTAR Biotechnology, Inc.

▪ Out-Licensing
▪ Collaborative R&D for drug discovery
▪ Clinical collaboration on iPSC-based cell therapies

MycoMagic Biotechnology

▪ Out-Licensing
▪ Collaborative product development
▪ Academic/ Industry Research partner

OBI Pharma, Inc.

ADC platform technologies - OBI is looking for collaborative R&D and out-license opportunities to create first- or best-in-class ADCs.
OBI’s novel cancer therapeutics – OBI is seeking out-licensing opportunities to expedite the clinical development of our pipeline products.

PharmaEssentia Corp.

Licensing

PrecisemAb Biotech Co., Ltd.

▪ Cooperation Partners of Lead Product-PSM101
▪ Strategic Partners of ADC.
▪ Customized Antibody Lock design service
▪ Out-licensing of Lock-antibodies

Taiwan Universe BioMedicine

▪ Out-Licensing
▪ Collaborative R&D

AHEAD Medicine Corporation

▪ Out-licensing
▪ Collaborative R&D

BioPro Scientific

▪ Collaborative, the device can be used for patient screening in clinical trials as the preselection tool of specific group with the same pathological brain signals.
▪ Collaborative, the device can be used for high density EEG collection identifying patient cohort based on the brain signals.

Dotspace Inc.

▪ Distributors
▪ Sales representatives
▪ Clinical Trial Collaboration

Lixel Inc.

▪ Direct sales
▪ Authorized dealers
▪ Authorized agent
▪ Collaborative R&D

IPreg Inc.

▪ Distribution
▪ In-/Out-Licensing
▪ CDMO
▪ Collaborative R&D

Moleculex Co., Ltd.

▪ Out-Licensing of Mucover Intra-Oral Patch for Oral Mucositis
▪ Out-Licensing of Mucoat Oral Rinse for Oral Mucositis
▪ Cooperation on Transmucosal Drug Delivery R&D
▪ Distribution Partnership (Marketing Authorization Holder)
▪ Seeking a $1 million investment for pivotal post-market clinical trials.

Origin Biotechnology Co.,Ltd

▪ Collaborative R&D
▪ OEM/ODM
▪ Product distribution
▪ Product Agency
▪ CRO

QT Medical Inc.

Distribution, Collaborative R&D, Project Collaboration, Cross-Industry Alliance

Bora Biologics Co., Ltd.

BORA’s team is here to discuss how we can become a trusted partner to help bring your breakthrough biologics successfully to market utilizing our platform & unique developer experience.
▪ Biologics CDMO: Establishing Cell Line, Process Optimization, Analytical/Formulation Development, Tox Study Material, cGMP Manufacturing, Global Quality, Stability Programs, Clinical Support

KriSan Biotech

▪ Collaborative R&D
▪ New drug development company
▪ CRO

Anbogen Therapeutics

▪ Out-licensing
▪ Collaborative R&D

ImmunAdd Inc.

▪ Collaborative R&D
▪ CDMP
▪ In-/Out-Licensing

Neural Rejuvenation Team (NRT), Biomedical Translation Research Center (BioTReC), Academia Sinica

▪ Out-licensing
▪ Co-development

Sinew Pharma Inc.

▪ licensing
▪ Co-Development
▪ Strategic Alliance

TAHO Pharmaceuticals Ltd.

Seeking out-licensing, CDMO opportunities for novel drug delivery systems

AB DigiHealth Inc.

▪ Sub-licensing
▪ Collaborative R&D
▪ Agency/Distributor

AcroCyte Therapeutics

▪ Looking for distributors for 3D culture market
▪ Targeting B2B or B2C clients who are interested in organoid/3D culture

CancerFree Biotech

▪ Joint Drug Discovery: Partnering for breakthrough research.
▪ U.S. Partners Wanted: Collaborating with CROs, pharma, and academia.
▪ Platform/Product Development: Transforming scientific breakthroughs into tangible advancements.

Elixiron Immunotherapeutics

▪ We plan to raise series B funding in 2H 2024 to accelerate the development of our clinical assets.
▪ We also welcome the opportunities of out-licensing or co-development.

Everfront Biotech

▪ Collaborative RD: US
▪ Out-licensing: Other countries

Health Ever Bio-Tech Co., Ltd.

• Out-Licensing
• Collaborative R&D

Hughes Biotechnology Co., Ltd.

PARTNERING OBJECTIVES
▪ Seeking collaborative opportunities in high-potent active ingredient development.
▪ Partnering on clinical studies.
▪ RenoSorbTM technology technical platform service

Oneness Biotech Co., Ltd.

Seeking out-licensing and collaborative R&D opportunities for first-in-class drugs based on innovative proprietary technology.

Pythia Biotech LTD

Collaborative R&D

Simpson Biotech Co., Ltd.

• Out-Licensing
• CDMO for recombinant proteins

Suntec Medical, Inc.

Initiate the business discussions for STM-001, 002, 003 licensing or collaborations (product handover after receiving FDA “breakthrough” designations).

Trust Bio-sonics Inc.

▪ Out-Licensing
▪ Collaborative R&D
▪ CDMO for Microbubble Formulation

TLC BioSciences

▪ Out-Licensing
▪ Collaborative R&D

Xantho Biotechnology Co., LTD

Out-Licensing
GM-XANTHO is available for out-licensing with rights in drug development and commercialization.

Agricultural Technology Research Institute

Collaborative R&D. We offer animal study can evaluate efficacy, toxicity study using pig model and bio-safety service to biotechnology companies. We want to contact the exhibitors help to screen potential candidate and accelerate new drug development.

Biomedical Translation Research Center (BioTReC), Academia Sinica

▪ Collaborating with international bio-cluster/ bio-park, accelerator, incubation center, global pharma, government agency, biotech association, venture capital;
▪ Space for startup related new drug discovery, smart healthcare & precision medicine;
▪ Translational medical research cooperation;
▪ Core facility support

Central Taiwan Science Park

▪ Collaborative R&D
▪ CDMO

China Productivity Center

Seeking in-/out-licensing, collaborative R&D, CDMO opportunities for Taiwanese biotechnology and Medicine companies.

Department of Academia Industry Collaboration and Science Park Affairs National Science and Technology Council

▪ Innovation and entrepreneurship
▪ Academia-industry collaboration
▪ Startups
▪ Talent cultivation

Development Center for Biotechnology

Out-Licensing, Collaborative R&D

Department of Industrial Technology, MOEA

Hsinchu Science Park Bureau, National Science and Technology Council

▪ Providing top-tier infrastructure and comprehensive one-stop services.
▪ Promoting industry-academia R&D collaboration. Creating a cluster of innovative ventures in world arena.
▪ Creating a cluster of innovative ventures in world arena.

Industrial Development Administration, Ministry of Economic Affairs

Industrial Technology Research Institute

▪ R&D Collaboration
▪ CDMO/ CRO
▪ Out-Licensing
▪ GxP Trial Production

Medical and Pharmaceutical Industry Technology and Development Center

CDMO, Co-development, Tech-transfer of pharmaceutical products, medical devices, botanical products and stem cell therapy products

Ministry of Agriculture

Ministry of Health and Welfare of the Republic of China

The MOHW’s diversified responsibilities include health policy planning and promotion, prevention and control of disease, food safety, drug management, social insurance and welfare, relief and protective services.

National Health Research Institutes

▪ R&D Collaboration
▪ Licensing

National Science and Technology Council

▪ IP/Tech feasibility and analysis for pharmaceuticals and medical devices
▪ Prototyping service for pharmaceuticals and medical devices
▪ Marketing analysis and regulatory compliance support for pharmaceuticals and medical devices
▪ Accelerate commercialization for pharmaceuticals and medical devices

Southern Taiwan Science Park Bureau, National Science and Technology Council

Collaborative R&D, CDMO

Startup Island TAIWAN

Startup Island TAIWAN demonstrates the strong ambition and capabilities of Taiwan tech startups as well as their intention and ability to contribute to other startup ecosystems around the world. We hope to be your gateway to Taiwan’s startup ecosystem.